Skip to content

The Effects of Mindfulness-Based Stress Reduction on Negative Self-Representations in Social Anxiety Disorder—A Randomized Wait-List Controlled Trial

Liguo He, Wei Han, Zhan Shi

Frontiers in Psychiatry May 12, 2021 DOI: 10.3389/fpsyt.2021.582333 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 85
Population Individuals with social anxiety disorder
Intervention Mindfulness-based stress reduction (MBSR)
Duration 12-week intervention
Topics Meditation Anxiety
Keywords Self-representations Self-related processing Other-related processing Social anxiety
Key findings MBSR reduced the self-reference effect for negative adjectives, and the resulting equilibrium in memory performance between self and other conditions predicted decreases in social anxiety symptoms.

Abstract

This study examines the impact of mindfulness-based stress reduction (MBSR) vs. wait list (WL) on the self-reference effect involving negative adjectives in individuals with social anxiety disorder (SAD). Eighty-five participants with SAD were randomly assigned to 12 weeks of MBSR or WL and completed an incidental SRE task that assessed treatment-related negative self-representations. Self-related negative adjectives were worse remembered in MBSR than in WL, and other-related negative adjectives were better remembered in MBSR than in WL. No differences emerged between the levels of self- and other-related processing for adjectives in MBSR. Moreover, the MBSR-related decreases in the difference in recognition memory performance between self and other conditions, that is, the treatment-related equilibrium, could predict the MBSR-related decreases in social anxiety symptoms. The selfless functioning and self-other control that can provide reasonable interpretations for these findings were discussed.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics